Pharma Archives - Page 32 of 64 - Life Sciences Times

Stylus Medicine Launches With $85M to Advance In Vivo Genetic Medicines and Next-Generation CAR-T Therapies

May 13, 2025

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

May 12, 2025

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

May 9, 2025

THIS WEEK'S STORIES

Japan Approves Sarepta’s Gene Therapy ELEVIDYS for Duchenne Muscular Dystrophy

May 13, 2025

Denali Growth Partners Closes $400 Million Second Fund to Back High-Growth, Capital-Efficient Companies

May 13, 2025

Redwire Chief Scientist Dr. Kenneth Savin Named to TIME100 Health List for Pioneering Space-Based Biotech Research

May 8, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Japan Approves Sarepta’s Gene Therapy ELEVIDYS for Duchenne Muscular Dystrophy

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

Pioneer Institute Tool Finds Drug Price Controls Raising Costs for Many Medicare Patients

What’s a fair price for a drug that’s never developed?

AstraZeneca’s IMFINZI Shows Significant Benefit in Early Bladder Cancer, Phase III Trial Finds

Most Read

K Health’s AI Physician Mode Joins Mayo Clinic Platform to Boost Primary Care Efficiency

FDA Approves GE HealthCare’s Optison for Pediatric Use, Expanding Access to Enhanced Heart Imaging

Vicarious Surgical Partners with UMass Memorial Medical Center to Advance Robotic Surgery Integration

Freespira Gains FDA Clearance for At-Home Anxiety and PTSD Treatment for Adolescents

EDITOR PICKS

Stylus Medicine Launches With $85M to Advance In Vivo Genetic Medicines and Next-Generation CAR-T Therapies

Ensoma Receives FDA Clearance to Begin Clinical Trials for First In Vivo Gene Insertion Therapy for X-CGD

Despite Anti-Vaccine Rhetoric, Global Healthy Living Foundation Sees Strong Interest in Vaccine Education from Chronically Ill Patients

THIS WEEK'S STORIES

Japan Approves Sarepta’s Gene Therapy ELEVIDYS for Duchenne Muscular Dystrophy

Denali Growth Partners Closes $400 Million Second Fund to Back High-Growth, Capital-Efficient Companies

Redwire Chief Scientist Dr. Kenneth Savin Named to TIME100 Health List for Pioneering Space-Based Biotech Research

POPULAR CATEGORY

ABOUT US

FOLLOW US